As a global leader in CDMO services, Asymchem delivers comprehensive, end-to-end solutions across the pharmaceutical value chain, leveraging over 25+ years of innovation and expertise. Building on a strong foundation in small molecule CDMO services, Asymchem has developed advanced capabilities in TIDES, biologics, drug products, clinical research, synthetic biology, and technology transfer. 

With a particular focus on peptides, Asymchem offers a wide range of peptides through flexible and customizable synthesis strategies to ensure both efficiency and high quality. Supported by a reliable supply chain, sufficient manufacturing capacity, and advanced downstream technologies, Asymchem is recognized as a leading provider of integrated peptide solutions globally. 

Our global network encompasses R&D and manufacturing facilities in China, the United States, the United Kingdom, and beyond, staffed by more than 9,000 professionals, with 45% dedicated to R&D. Trusted by global pharma and biotech leaders, Asymchem adheres to the highest cGMP and EHS standards, providing high-quality, cost-effective solutions that accelerate drug development.